Johnson & Johnson
JNJ
$167.33
$2.591.57%
NYSE
06/29/2025 | 03/30/2025 | 12/29/2024 | 09/29/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | 4.68% | 4.30% | 4.30% | 4.77% | 5.13% |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 4.68% | 4.30% | 4.30% | 4.77% | 5.13% |
Cost of Revenue | 8.61% | 7.42% | 4.61% | 4.84% | 4.21% |
Gross Profit | 2.97% | 2.95% | 4.16% | 4.74% | 5.54% |
SG&A Expenses | 4.87% | 5.47% | 8.16% | 7.64% | 9.61% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 8.79% | 7.69% | 8.09% | 8.06% | 5.83% |
Operating Income | -5.89% | -4.50% | -5.39% | -3.32% | 3.40% |
Income Before Tax | 40.21% | 32.60% | 10.79% | 25.22% | 39.01% |
Income Tax Expenses | 50.05% | 60.28% | 50.98% | 72.75% | 94.10% |
Earnings from Continuing Operations | 38.33% | 27.75% | 5.55% | 18.89% | 31.88% |
Earnings from Discontinued Operations | -- | -- | -- | -100.37% | 3,323.42% |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -40.39% | -43.32% | -59.99% | -57.59% | 191.24% |
EBIT | -5.89% | -4.50% | -5.39% | -3.32% | 3.40% |
EBITDA | -2.75% | -2.64% | -3.39% | -2.18% | 3.50% |
EPS Basic | -37.64% | -40.12% | -57.54% | -56.82% | 201.67% |
Normalized Basic EPS | -3.93% | 1.60% | 2.75% | 12.32% | 19.43% |
EPS Diluted | -37.40% | -39.94% | -57.43% | -56.62% | 203.01% |
Normalized Diluted EPS | -3.81% | 1.80% | 2.64% | 12.53% | 19.64% |
Average Basic Shares Outstanding | -4.52% | -6.29% | -8.04% | -3.51% | -3.37% |
Average Diluted Shares Outstanding | -4.63% | -6.47% | -7.97% | -3.81% | -3.67% |
Dividend Per Share | 4.37% | 4.20% | 4.47% | 4.74% | 5.02% |
Payout Ratio | 1.33% | 1.39% | 2.32% | 2.07% | -0.75% |